This Is MS Multiple Sclerosis Knowledge & Support Community

Scientist set to test the best way to treat newly diagnosed MS patients

UK patients are set to take part in a $10 million international clinical trial to discover whether giving MS patients the strongest available medicines from the beginning of their illness is more effective than waiting for the disease to progress...Read more - http://www.ms-uk.org/scientist-set-test ... s-patients

Ocrevus? Tysabri?

What about PML? I think 5-10 years of interferons with minimal PML risk is perfectly acceptable as long as relapse frequency and severity are acceptable. Strong drugs in early years is not worth the PML risk.